<!doctype html><html lang=en><head><meta charset=utf-8><meta name=description content="Indikation  [[Ödeme]]: [[Herz]] ([[Herzinsuffizienz]], [[Lungenödem]]), [[Niere]] ([[Nephrotisches Syndrom]]), [[Leber]] ([[Leberzirrhose]]) [[CKD]] (auch bei [[GFR]] <30 einsetzbar)   Wirkstoffe:: [[Furosemid]] (akut), Torasemid (längerfristig) Wirkmechanismus:: Blockade [[NKCC2]]  [[Harnkonzentrierung]]↓ Venöse [[Vasodilatation]] ([[Vorlast]]↓), Hemmung [[Macula-Densa-Mechanismus]] Lineare Dosis-Wirkung-Beziehung (hight-ceiling [[Diuretika]]) Nach 4-6 h postdiuretische kompensatorische Natriumretention   [[UAW]]  Elektrolytverlust: ==[[K+]]↓==, [[Ca2+]], [[Mg2+]], [[Cl-]] ==Ototoxizität== ==[[Exsikkose]]==, Hypovolämie → [[Thrombose]]-[[Risiko]]↑ [[Hyperglycämie]]-Neigung, [[Hyperurikämie]] (Gichtanfall)   KI  [[Anurie]]/[[Oligurie]], [[Hypovolämie]] [[Elektrolytstörungen]]: [[Hypokaliämie]], [[Hyponatriämie]] Allergie gegen Sulfonamide     Mythbusting  DGIM Klug entscheiden:: Die Gabe von Schleifendiuretika beim oligoanurischen Patienten mit [[Nierenversagen]] soll nicht erfolgen."><meta property="og:title" content="Schleifendiuretika"><meta property="og:description" content="Indikation  [[Ödeme]]: [[Herz]] ([[Herzinsuffizienz]], [[Lungenödem]]), [[Niere]] ([[Nephrotisches Syndrom]]), [[Leber]] ([[Leberzirrhose]]) [[CKD]] (auch bei [[GFR]] <30 einsetzbar)   Wirkstoffe:: [[Furosemid]] (akut), Torasemid (längerfristig) Wirkmechanismus:: Blockade [[NKCC2]]  [[Harnkonzentrierung]]↓ Venöse [[Vasodilatation]] ([[Vorlast]]↓), Hemmung [[Macula-Densa-Mechanismus]] Lineare Dosis-Wirkung-Beziehung (hight-ceiling [[Diuretika]]) Nach 4-6 h postdiuretische kompensatorische Natriumretention   [[UAW]]  Elektrolytverlust: ==[[K+]]↓==, [[Ca2+]], [[Mg2+]], [[Cl-]] ==Ototoxizität== ==[[Exsikkose]]==, Hypovolämie → [[Thrombose]]-[[Risiko]]↑ [[Hyperglycämie]]-Neigung, [[Hyperurikämie]] (Gichtanfall)   KI  [[Anurie]]/[[Oligurie]], [[Hypovolämie]] [[Elektrolytstörungen]]: [[Hypokaliämie]], [[Hyponatriämie]] Allergie gegen Sulfonamide     Mythbusting  DGIM Klug entscheiden:: Die Gabe von Schleifendiuretika beim oligoanurischen Patienten mit [[Nierenversagen]] soll nicht erfolgen."><meta property="og:type" content="website"><meta property="og:image" content="https://notes.vincentweber.net/icon.png"><meta property="og:url" content="https://notes.vincentweber.net/Schleifendiuretika/"><meta property="og:width" content="200"><meta property="og:height" content="200"><meta name=twitter:card content="summary"><meta name=twitter:title content="Schleifendiuretika"><meta name=twitter:description content="Indikation  [[Ödeme]]: [[Herz]] ([[Herzinsuffizienz]], [[Lungenödem]]), [[Niere]] ([[Nephrotisches Syndrom]]), [[Leber]] ([[Leberzirrhose]]) [[CKD]] (auch bei [[GFR]] <30 einsetzbar)   Wirkstoffe:: [[Furosemid]] (akut), Torasemid (längerfristig) Wirkmechanismus:: Blockade [[NKCC2]]  [[Harnkonzentrierung]]↓ Venöse [[Vasodilatation]] ([[Vorlast]]↓), Hemmung [[Macula-Densa-Mechanismus]] Lineare Dosis-Wirkung-Beziehung (hight-ceiling [[Diuretika]]) Nach 4-6 h postdiuretische kompensatorische Natriumretention   [[UAW]]  Elektrolytverlust: ==[[K+]]↓==, [[Ca2+]], [[Mg2+]], [[Cl-]] ==Ototoxizität== ==[[Exsikkose]]==, Hypovolämie → [[Thrombose]]-[[Risiko]]↑ [[Hyperglycämie]]-Neigung, [[Hyperurikämie]] (Gichtanfall)   KI  [[Anurie]]/[[Oligurie]], [[Hypovolämie]] [[Elektrolytstörungen]]: [[Hypokaliämie]], [[Hyponatriämie]] Allergie gegen Sulfonamide     Mythbusting  DGIM Klug entscheiden:: Die Gabe von Schleifendiuretika beim oligoanurischen Patienten mit [[Nierenversagen]] soll nicht erfolgen."><meta name=twitter:image content="https://notes.vincentweber.net/icon.png"><meta name=twitter:site content="vncntwbr"><title>Schleifendiuretika</title><meta name=viewport content="width=device-width,initial-scale=1"><link rel="shortcut icon" type=image/png href=https://notes.vincentweber.net//icon.png><link href=https://notes.vincentweber.net/styles.cfbac90e55cfef247c47edcca25506aa.min.css rel=stylesheet><link href=https://notes.vincentweber.net/styles/_light_syntax.86a48a52faebeaaf42158b72922b1c90.min.css rel=stylesheet id=theme-link><script src=https://notes.vincentweber.net/js/darkmode.079afcf69cec25e5cc7c3b65e0b059f9.min.js></script>
<script src=https://notes.vincentweber.net/js/util.a0ccf91e1937fe761a74da4946452710.min.js></script>
<link rel=preload href=https://cdn.jsdelivr.net/npm/katex@0.15.1/dist/katex.min.css as=style onload='this.onload=null,this.rel="stylesheet"' integrity=sha384-R4558gYOUz8mP9YWpZJjofhk+zx0AS11p36HnD2ZKj/6JR5z27gSSULCNHIRReVs crossorigin=anonymous><script defer src=https://cdn.jsdelivr.net/npm/katex@0.15.1/dist/katex.min.js integrity=sha384-z1fJDqw8ZApjGO3/unPWUPsIymfsJmyrDVWC8Tv/a1HeOtGmkwNd/7xUS0Xcnvsx crossorigin=anonymous></script>
<script defer src=https://cdn.jsdelivr.net/npm/katex@0.15.1/dist/contrib/auto-render.min.js integrity=sha384-+XBljXPPiv+OzfbB3cVmLHf4hdUFHlWNZN5spNQ7rmHTXpd7WvJum6fIACpNNfIR crossorigin=anonymous></script>
<script defer src=https://cdn.jsdelivr.net/npm/katex@0.16.2/dist/contrib/copy-tex.min.js integrity=sha384-ww/583aHhxWkz5DEVn6OKtNiIaLi2iBRNZXfJRiY1Ai7tnJ9UXpEsyvOITVpTl4A crossorigin=anonymous></script>
<script async src=https://unpkg.com/@floating-ui/core@0.7.3></script>
<script async src=https://unpkg.com/@floating-ui/dom@0.5.4></script>
<script async src=https://notes.vincentweber.net/js/popover.aa9bc99c7c38d3ae9538f218f1416adb.min.js></script>
<script defer src=https://notes.vincentweber.net/js/code-title.60f1f75ed725d525c91d24e437dab0b1.min.js></script>
<script defer src=https://notes.vincentweber.net/js/clipboard.2913da76d3cb21c5deaa4bae7da38c9f.min.js></script>
<script defer src=https://notes.vincentweber.net/js/callouts.7723cac461d613d118ee8bb8216b9838.min.js></script>
<script>const SEARCH_ENABLED=!1,LATEX_ENABLED=!0,PRODUCTION=!0,BASE_URL="https://notes.vincentweber.net/",fetchData=Promise.all([fetch("https://notes.vincentweber.net/indices/linkIndex.32f43c72bc4f38ebd83a6fa63e426043.min.json").then(e=>e.json()).then(e=>({index:e.index,links:e.links})),fetch("https://notes.vincentweber.net/indices/contentIndex.a9770b53f8f7dc7bcaa6f5ce1911f3b7.min.json").then(e=>e.json())]).then(([{index:e,links:t},n])=>({index:e,links:t,content:n})),render=()=>{const e=new URL(BASE_URL),t=e.pathname,n=window.location.pathname,s=t==n;addCopyButtons(),addTitleToCodeBlocks(),addCollapsibleCallouts(),initPopover("https://notes.vincentweber.net",!0);const o=document.getElementById("footer");if(o){const e=document.getElementById("graph-container");if(!e)return requestAnimationFrame(render);e.textContent="";const t=s&&!1;drawGraph("https://notes.vincentweber.net",t,[{"/moc":"#4388cc"}],t?{centerForce:1,depth:-1,enableDrag:!0,enableLegend:!1,enableZoom:!0,fontSize:.5,linkDistance:1,opacityScale:3,repelForce:1,scale:1.4}:{centerForce:1,depth:1,enableDrag:!0,enableLegend:!1,enableZoom:!0,fontSize:.6,linkDistance:1,opacityScale:3,repelForce:2,scale:1.2})}var i=document.getElementsByClassName("mermaid");i.length>0&&import("https://unpkg.com/mermaid@9/dist/mermaid.esm.min.mjs").then(e=>{e.default.init()});function a(n){const e=n.target,t=e.className.split(" "),s=t.includes("broken"),o=t.includes("internal-link");plausible("Link Click",{props:{href:e.href,broken:s,internal:o,graph:!1}})}const r=document.querySelectorAll("a");for(link of r)link.className.includes("root-title")&&link.addEventListener("click",a,{once:!0})},init=(e=document)=>{addCopyButtons(),addTitleToCodeBlocks(),renderMathInElement(e.body,{delimiters:[{left:"$$",right:"$$",display:!0},{left:"$",right:"$",display:!1}],macros:{'’':"'"},throwOnError:!1})}</script><script type=module>
    import { attachSPARouting } from "https:\/\/notes.vincentweber.net\/js\/router.d6fe6bd821db9ea97f9aeefae814d8e7.min.js"
    attachSPARouting(init, render)
  </script><script defer data-domain=notes.vincentweber.net src=https://plausible.io/js/script.js></script>
<script>window.plausible=window.plausible||function(){(window.plausible.q=window.plausible.q||[]).push(arguments)}</script></head><body><div id=search-container><div id=search-space><input autocomplete=off id=search-bar name=search type=text aria-label=Search placeholder="Search for something..."><div id=results-container></div></div></div><script src=https://cdn.jsdelivr.net/npm/flexsearch@0.7.21/dist/flexsearch.bundle.js integrity="sha256-i3A0NZGkhsKjVMzFxv3ksk0DZh3aXqu0l49Bbh0MdjE=" crossorigin=anonymous defer></script>
<script defer src=https://notes.vincentweber.net/js/full-text-search.e6e2e0c213187ca0c703d6e2c7a77fcd.min.js></script><div class=singlePage><header><h1 id=page-title><a class=root-title href=https://notes.vincentweber.net/>Vincent's Notes</a></h1><div class=spacer></div><div id=search-icon><p>Search</p><svg tabindex="0" aria-labelledby="title desc" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 19.9 19.7"><title id="title">Search Icon</title><desc id="desc">Icon to open search</desc><g class="search-path" fill="none"><path stroke-linecap="square" d="M18.5 18.3l-5.4-5.4"/><circle cx="8" cy="8" r="7"/></g></svg></div><div class=darkmode><input class=toggle id=darkmode-toggle type=checkbox tabindex=-1>
<label id=toggle-label-light for=darkmode-toggle tabindex=-1><svg xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" id="dayIcon" viewBox="0 0 35 35" style="enable-background:new 0 0 35 35"><title>Light Mode</title><path d="M6 17.5C6 16.672 5.328 16 4.5 16h-3C.672 16 0 16.672.0 17.5S.672 19 1.5 19h3C5.328 19 6 18.328 6 17.5zM7.5 26c-.414.0-.789.168-1.061.439l-2 2C4.168 28.711 4 29.086 4 29.5 4 30.328 4.671 31 5.5 31c.414.0.789-.168 1.06-.44l2-2C8.832 28.289 9 27.914 9 27.5 9 26.672 8.329 26 7.5 26zm10-20C18.329 6 19 5.328 19 4.5v-3C19 .672 18.329.0 17.5.0S16 .672 16 1.5v3C16 5.328 16.671 6 17.5 6zm10 3c.414.0.789-.168 1.06-.439l2-2C30.832 6.289 31 5.914 31 5.5 31 4.672 30.329 4 29.5 4c-.414.0-.789.168-1.061.44l-2 2C26.168 6.711 26 7.086 26 7.5 26 8.328 26.671 9 27.5 9zM6.439 8.561C6.711 8.832 7.086 9 7.5 9 8.328 9 9 8.328 9 7.5c0-.414-.168-.789-.439-1.061l-2-2C6.289 4.168 5.914 4 5.5 4 4.672 4 4 4.672 4 5.5c0 .414.168.789.439 1.06l2 2.001zM33.5 16h-3c-.828.0-1.5.672-1.5 1.5s.672 1.5 1.5 1.5h3c.828.0 1.5-.672 1.5-1.5S34.328 16 33.5 16zM28.561 26.439C28.289 26.168 27.914 26 27.5 26c-.828.0-1.5.672-1.5 1.5.0.414.168.789.439 1.06l2 2C28.711 30.832 29.086 31 29.5 31c.828.0 1.5-.672 1.5-1.5.0-.414-.168-.789-.439-1.061l-2-2zM17.5 29c-.829.0-1.5.672-1.5 1.5v3c0 .828.671 1.5 1.5 1.5s1.5-.672 1.5-1.5v-3C19 29.672 18.329 29 17.5 29zm0-22C11.71 7 7 11.71 7 17.5S11.71 28 17.5 28 28 23.29 28 17.5 23.29 7 17.5 7zm0 18c-4.136.0-7.5-3.364-7.5-7.5s3.364-7.5 7.5-7.5 7.5 3.364 7.5 7.5S21.636 25 17.5 25z"/></svg></label><label id=toggle-label-dark for=darkmode-toggle tabindex=-1><svg xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" id="nightIcon" viewBox="0 0 100 100" style="enable-background='new 0 0 100 100'"><title>Dark Mode</title><path d="M96.76 66.458c-.853-.852-2.15-1.064-3.23-.534-6.063 2.991-12.858 4.571-19.655 4.571C62.022 70.495 50.88 65.88 42.5 57.5 29.043 44.043 25.658 23.536 34.076 6.47c.532-1.08.318-2.379-.534-3.23-.851-.852-2.15-1.064-3.23-.534-4.918 2.427-9.375 5.619-13.246 9.491-9.447 9.447-14.65 22.008-14.65 35.369.0 13.36 5.203 25.921 14.65 35.368s22.008 14.65 35.368 14.65c13.361.0 25.921-5.203 35.369-14.65 3.872-3.871 7.064-8.328 9.491-13.246C97.826 68.608 97.611 67.309 96.76 66.458z"/></svg></label></div></header><article><h1>Schleifendiuretika</h1><p class=meta>Last updated
Apr 26, 2023
<a href=https://github.com/diabolicvincent-git/quartz/tree/hugo/content/Schleifendiuretika.md rel=noopener>Edit Source</a></p><ul class=tags><li><a href=https://notes.vincentweber.net/tags/Modul/m14/>Modul m14</a></li><li><a href=https://notes.vincentweber.net/tags/Fach/Nephrologie/>Fach nephrologie</a></li><li><a href=https://notes.vincentweber.net/tags/Fach/Kardiologie/>Fach kardiologie</a></li><li><a href=https://notes.vincentweber.net/tags/Fach/Pharmakologie/Medikament/>Fach pharmakologie medikament</a></li><li><a href=https://notes.vincentweber.net/tags/Mythbusting/DGIM-Klug-entscheiden/>Mythbusting dgim klug entscheiden</a></li></ul><aside class=mainTOC><details><summary>Table of Contents</summary><nav id=TableOfContents><ol><li><ol><li><a href=#mythbusting>Mythbusting</a></li></ol></li></ol></nav></details></aside><ul><li><strong>Indikation</strong><ul><li><em><a href=/%C3%96deme rel=noopener class=internal-link data-src=/%C3%96deme>Ödeme</a>:</em> <a href=/Herz rel=noopener class=internal-link data-src=/Herz>Herz</a> (<a href=/Herzinsuffizienz rel=noopener class=internal-link data-src=/Herzinsuffizienz>Herzinsuffizienz</a>, <a href=/Lungen%C3%B6dem rel=noopener class=internal-link data-src=/Lungen%C3%B6dem>Lungenödem</a>), <a href=/Niere rel=noopener class=internal-link data-src=/Niere>Niere</a> (<a href=/Nephrotisches-Syndrom rel=noopener class=internal-link data-src=/Nephrotisches-Syndrom>Nephrotisches Syndrom</a>), <a href=/Leber rel=noopener class=internal-link data-src=/Leber>Leber</a> (<a href=/Leberzirrhose rel=noopener class=internal-link data-src=/Leberzirrhose>Leberzirrhose</a>)</li><li><em><a href=/CKD rel=noopener class=internal-link data-src=/CKD>CKD</a></em> (auch bei <a href=/GFR rel=noopener class=internal-link data-src=/GFR>GFR</a> &lt;30 einsetzbar)</li></ul></li><li><strong>Wirkstoffe</strong>:: <a href=/fUROsemid rel=noopener class=internal-link data-src=/fUROsemid>Furosemid</a> (akut), Torasemid (längerfristig)</li><li><strong>Wirkmechanismus</strong>:: Blockade <a href=/NKCC2 rel=noopener class=internal-link data-src=/NKCC2>NKCC2</a><ul><li><a href=/Harnkonzentrierung rel=noopener class=internal-link data-src=/Harnkonzentrierung>Harnkonzentrierung</a>↓</li><li>Venöse <a href=/Vasodilatation rel=noopener class=internal-link data-src=/Vasodilatation>Vasodilatation</a> (<a href=/Vorlast rel=noopener class=internal-link data-src=/Vorlast>Vorlast</a>↓), Hemmung <a class="internal-link broken">Macula-Densa-Mechanismus</a></li><li>Lineare Dosis-Wirkung-Beziehung (<em>hight-ceiling <a href=/Diuretika rel=noopener class=internal-link data-src=/Diuretika>Diuretika</a></em>)</li><li>Nach 4-6 h <em>postdiuretische kompensatorische Natriumretention</em></li></ul></li><li><strong><a href=/UAW rel=noopener class=internal-link data-src=/UAW>UAW</a></strong><ul><li><em>Elektrolytverlust:</em> ==<a href=/K+ rel=noopener class=internal-link data-src=/K+>K+</a>↓==, <a href=/Ca2+ rel=noopener class=internal-link data-src=/Ca2+>Ca2+</a>, <a href=/Mg2+ rel=noopener class=internal-link data-src=/Mg2+>Mg2+</a>, <a href=/Cl- rel=noopener class=internal-link data-src=/Cl->Cl-</a></li><li><em><mark>Ototoxizität</mark></em></li><li><em>==<a href=/Exsikkose rel=noopener class=internal-link data-src=/Exsikkose>Exsikkose</a>==, Hypovolämie</em> → <a href=/Thrombose rel=noopener class=internal-link data-src=/Thrombose>Thrombose</a>-<a href=/Risiko rel=noopener class=internal-link data-src=/Risiko>Risiko</a>↑</li><li><a href=/Hyperglyc%C3%A4mie rel=noopener class=internal-link data-src=/Hyperglyc%C3%A4mie>Hyperglycämie</a>-Neigung, <a href=/Hyperurik%C3%A4mie rel=noopener class=internal-link data-src=/Hyperurik%C3%A4mie>Hyperurikämie</a> (Gichtanfall)</li></ul></li><li><strong>KI</strong><ul><li><a href=/Anurie rel=noopener class=internal-link data-src=/Anurie>Anurie</a>/<a href=/Oligurie rel=noopener class=internal-link data-src=/Oligurie>Oligurie</a>, <a href=/Hypovol%C3%A4mie rel=noopener class=internal-link data-src=/Hypovol%C3%A4mie>Hypovolämie</a></li><li><a href=/Elektrolytst%C3%B6rungen rel=noopener class=internal-link data-src=/Elektrolytst%C3%B6rungen>Elektrolytstörungen</a>: <a href=/Hypokali%C3%A4mie rel=noopener class=internal-link data-src=/Hypokali%C3%A4mie>Hypokaliämie</a>, <a href=/Hyponatri%C3%A4mie rel=noopener class=internal-link data-src=/Hyponatri%C3%A4mie>Hyponatriämie</a></li><li>Allergie gegen Sulfonamide</li></ul></li></ul><hr><a href=#mythbusting><h3 id=mythbusting><span class=hanchor arialabel=Anchor># </span>Mythbusting</h3></a><ul><li><em>DGIM Klug entscheiden</em>:: Die Gabe von Schleifendiuretika beim oligoanurischen Patienten mit <a href=/Nierenversagen rel=noopener class=internal-link data-src=/Nierenversagen>Nierenversagen</a> soll nicht erfolgen.</li></ul></article><hr><div class=page-end id=footer><div class=backlinks-container><h3>Backlinks</h3><ul class=backlinks><li><a href=/CKD/ data-ctx=Schleifendiuretika data-src=/CKD class=internal-link>CKD</a></li><li><a href=/Cochlea/ data-ctx=Schleifendiuretika data-src=/Cochlea class=internal-link>Cochlea</a></li><li><a href=/Diuretika/ data-ctx=Schleifendiuretika data-src=/Diuretika class=internal-link>Diuretika</a></li><li><a href=/Herzinsuffizienz/ data-ctx=Schleifendiuretika data-src=/Herzinsuffizienz class=internal-link>Herzinsuffizienz</a></li><li><a href=/Herzinsuffizienz-Therapie/ data-ctx=Schleifendiuretika data-src=/Herzinsuffizienz-Therapie class=internal-link>Herzinsuffizienz-Therapie</a></li><li><a href=/Hyperkali%C3%A4mie/ data-ctx=Schleifendiuretika data-src=/Hyperkali%C3%A4mie class=internal-link>Hyperkaliämie</a></li><li><a href=/IMPP-Arzneistoffe/ data-ctx=Schleifendiuretika data-src=/IMPP-Arzneistoffe class=internal-link>IMPP-Arzneistoffe</a></li><li><a href=/Innenohrfl%C3%BCssigkeiten/ data-ctx=Schleifendiuretika data-src=/Innenohrfl%C3%BCssigkeiten class=internal-link>Innenohrflüssigkeiten</a></li><li><a href=/Leberzirrhose/ data-ctx=Schleifendiuretika data-src=/Leberzirrhose class=internal-link>Leberzirrhose</a></li><li><a href=/Nierenversagen/ data-ctx=Schleifendiuretika data-src=/Nierenversagen class=internal-link>Nierenversagen</a></li><li><a href=/Pharmakologie/ data-ctx=Schleifendiuretika data-src=/Pharmakologie class=internal-link>Pharmakologie</a></li><li><a href=/Thrombopenie/ data-ctx=Schleifendiuretika data-src=/Thrombopenie class=internal-link>Thrombopenie</a></li><li><a href=/fUROsemid/ data-ctx=Schleifendiuretika data-src=/fUROsemid class=internal-link>fUROsemid</a></li></ul></div><div><script async src=https://cdn.jsdelivr.net/npm/d3@6.7.0/dist/d3.min.js integrity="sha256-+7jaYCp29O1JusNWHaYtgUn6EhuP0VaFuswhNV06MyI=" crossorigin=anonymous></script><h3>Interactive Graph</h3><div id=graph-container></div><style>:root{--g-node:var(--secondary);--g-node-active:var(--primary);--g-node-inactive:var(--visited);--g-link:var(--outlinegray);--g-link-active:#5a7282}</style><script src=https://notes.vincentweber.net/js/graph.6579af7b10c818dbd2ca038702db0224.js></script></div></div><div id=contact_buttons><footer><p>Made by Vincent Weber using <a href=https://github.com/jackyzha0/quartz>Quartz</a>, © 2023</p><ul><li><a href=https://notes.vincentweber.net/>Home</a></li><li><a href=https://twitter.com/vncntwbr>Twitter</a></li></ul></footer></div></div></body></html>